VYNE Therapeutics Inc. — Form D

VYNE Therapeutics Inc. of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-18. The offering totals $300K, of which $300K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Andrew PerlmanDirectorAtlanta, GA
Ketan L PatelDirectorCalabasas, CA
James LarrickDirectorOsage Beach, MO
James LarrickExecutive OfficerOsage Beach, MO
SHARON BARBARIDirectorBRIDGEWATER, NJ
MUTYA HARSCHExecutive OfficerBRIDGEWATER, NJ
TYLER ZERONDAExecutive OfficerBRIDGEWATER, NJ
DAVID DOMZALSKIDirectorBRIDGEWATER, NJ
DAVID DOMZALSKIExecutive OfficerBRIDGEWATER, NJ
ELISABETH SANDOVALDirectorBRIDGEWATER, NJ
PATRICK LEPOREDirectorBRIDGEWATER, NJ
STEVEN BASTADirectorBRIDGEWATER, NJ
IAIN STUARTExecutive OfficerBRIDGEWATER, NJ
ANTHONY BRUNODirectorBRIDGEWATER, NJ
Albert L ChaDirectorMenlo Park, CA
Steven L BastaDirectorMenlo Park, CA
Steven L BastaExecutive OfficerMenlo Park, CA
John L CreecyDirectorMenlo Park, CA
Scott L WhitcupDirectorMenlo Park, CA
Aaron L RoystonDirectorMenlo Park, CA
Ted L EbelDirectorMenlo Park, CA
David L CollierDirectorMenlo Park, CA
Edward SchnipperDirectorGrand Prairie, TX

Other filings by this issuer (3)

FiledFormOfferingSold
2023-11-16D$88.2M$88.2M
2017-07-28D$50.5M$50.5M
2013-01-07D$15.0M$500K

More